Biotech startups that raised Series B
Source: FundingWatcher. Data as of 4 September 2026.
1,411
Companies
$47.9B
Last round total
100
Rows shown
4 September 2026
Data as of
Latest rounds
Most recent round first
100 rows
| # | Company | Round | Amount | Date | City | Sector |
|---|---|---|---|---|---|---|
| 1 | Pixelgen Technologies | Series B | $15.5M | 2026-08-20 | Stockholm | Biotech |
| 2 | Computomics | Series B | $7.3M | 2026-08-18 | Tübingen | Biotech |
| 3 | Georgiamune | Series B | $92.7M | 2026-08-17 | Gaithersburg | Biotech |
| 4 | Khartis Therapeutics | Series B | $50.0M | 2026-08-13 | San Diego | Biotech |
| 5 | Hongxin Biology | Series B | $14.0M | 2026-08-13 | Shenzhen | Biotech |
| 6 | InduPro | Series B | $77.0M | 2026-08-12 | Seattle | Biotech |
| 7 | Amplifica | Series B | $26.0M | 2026-08-12 | San Diego | Biotech |
| 8 | Vaderis Therapeutics | Series B | $152.0M | 2026-08-11 | Basel | Biotech |
| 9 | Flagler Health | Series B | $50.0M | 2026-08-11 | New York | Biotech |
| 10 | Aureka Biotechnologies | Series B | $100.0M | 2026-08-10 | Laguna Hills | Artificial intelligence |
| 11 | Expedition Therapeutics | Series B | $115.0M | 2026-08-05 | San Francisco | Biotech |
| 12 | Mironid | Series B | $45.9M | 2026-08-05 | Newhouse | Biotech |
| 13 | Claris Biotherapeutics | Series B | $118.0M | 2026-07-28 | Jersey City | Biotech |
| 14 | Layerwave Bio | Series B | $13.8M | 2026-07-28 | Daxing | Biotech |
| 15 | Crystalys Therapeutics | Series B | $130.0M | 2026-07-22 | San Diego | Biotech |
| 16 | Draig Therapeutics | Series B | $65.0M | 2026-07-14 | Cardiff | Biotech |
| 17 | Illuminare Biotechnologies | Series B | $2.4M | 2026-07-14 | Princeton | Biotech |
| 18 | Huaxia Yuan Group | Series B | 2026-07-14 | Minhang | Biotech | |
| 19 | MindRank AI | Series B | $52.0M | 2026-07-08 | Shanghai | Artificial intelligence |
| 20 | Kuehnle Agrosystems | Series B | $3.0M | 2026-07-06 | Honolulu | Biotech |
| 21 | Pyrotech | Series B | 2026-07-03 | Changping | Biotech | |
| 22 | Inocras | Series B | $20K | 2026-07-01 | San Diego | Artificial intelligence |
| 23 | Neusignal Therapeutics | Series B | $32.8M | 2026-06-30 | Tokyo | Biotech |
| 24 | Etern | Series B | 2026-06-30 | Shanghai | Biotech | |
| 25 | The Protein Brewery | Series B | $20.5M | 2026-06-29 | Breda | Biotech |
| 26 | Oblenio Bio | Series B | $62.0M | 2026-06-25 | Oakland | Biotech |
| 27 | Ollin Biosciences | Series B | $330.0M | 2026-06-24 | Austin | Biotech |
| 28 | Osanni Bio | Series B | $190.0M | 2026-06-23 | San Francisco | Biotech |
| 29 | Nura Bio | Series B | $73.8M | 2026-06-22 | South San Francisco | Biotech |
| 30 | Cour Pharmaceuticals Development | Series B | $50.0M | 2026-06-18 | Skokie | Biotech |
| 31 | Vertoro | Series B | $11.5M | 2026-06-17 | Geleen | Biotech |
| 32 | FNCT Biotech | Series B | $14.0M | 2026-06-16 | Seoul | Biotech |
| 33 | HMNC Brain Health | Series B | $50.0M | 2026-06-15 | München | Biotech |
| 34 | ThunderBio Innovation | Series B | $17.7M | 2026-06-15 | Jiaxing | Biotech |
| 35 | Zumutor Biologics | Series B | $7.3M | 2026-06-13 | Woburn | Biotech |
| 36 | SonoThera | Series B | $125.0M | 2026-06-10 | South San Francisco | Biotech |
| 37 | City Therapeutics | Series B | $99.5M | 2026-06-08 | Cambridge | Biotech |
| 38 | Ona Therapeutics | Series B | $86.6M | 2026-06-04 | Barcelona | Biotech |
| 39 | Contraline | Series B | $92.5M | 2026-06-02 | Charlottesville | Biotech |
| 40 | HemaCell | Series B | $14.8M | 2026-06-02 | Suzhou | Biotech |
| 41 | Elemental Machines | Series B | $5.7M | 2026-05-27 | Cambridge | Artificial intelligence |
| 42 | Phytolon | Series B | $23.6M | 2026-05-26 | Yoqne`am `illit | Biotech |
| 43 | Furong Biotech | Series B | $14.7M | 2026-05-20 | Suzhou | Biotech |
| 44 | Bivision | Series B | $58.8M | 2026-05-18 | Shanghai | Biotech |
| 45 | CREATE Medicines | Series B | $122.0M | 2026-05-14 | Cambridge | Biotech |
| 46 | NVision Quantum Technologies | Series B | $38.0M | 2026-05-13 | Ulm | Biotech |
| 47 | Starna Therapeutics | Series B | $40.0M | 2026-05-11 | Suzhou | Biotech |
| 48 | Ruijiakang | Series B | $1.4M | 2026-05-11 | Wuhan | Biotech |
| 49 | LTZ Therapeutics | Series B | $38.0M | 2026-05-06 | San Francisco | Biotech |
| 50 | Windward Bio | Series B | $165.0M | 2026-05-04 | Basel | Biotech |
| 51 | Allyx Therapeutics | Series B | $26.5M | 2026-05-01 | New Haven | Biotech |
| 52 | Novamab | Series B | $43.9M | 2026-04-24 | Shanghai | Biotech |
| 53 | Hexaell Biotech | Series B | $14.6M | 2026-04-24 | Shanghai | Biotech |
| 54 | Ray Therapeutics | Series B | $125.0M | 2026-04-21 | San Diego | Biotech |
| 55 | Restore Vision | Series B | $8.2M | 2026-04-15 | Tokyo | Biotech |
| 56 | Spiral Therapeutics | Series B | $27.0M | 2026-04-14 | San Francisco | Biotech |
| 57 | Neomorph | Series B | $100.0M | 2026-04-13 | San Diego | Biotech |
| 58 | AnBogen Therapeutics | Series B | $7.3M | 2026-04-13 | Nankang | Biotech |
| 59 | Sidewinder Therapeutics | Series B | $137.0M | 2026-04-08 | San Diego | Biotech |
| 60 | Incyclix Bio | Series B | $5.0M | 2026-04-08 | Durham | Biotech |
| 61 | Ruijiming Biological | Series B | $2.5M | 2026-04-08 | Shandong | Biotech |
| 62 | Kytopen | Series B | $1.6M | 2026-04-07 | Cambridge | Biotech |
| 63 | DynaFlow | Series B | $14.5M | 2026-04-03 | Fengtai | Biotech |
| 64 | Syneron | Series B | $150.0M | 2026-03-31 | Guangzhou | Artificial intelligence |
| 65 | Ambrosia Biosciences | Series B | $100.0M | 2026-03-31 | Boulder | Biotech |
| 66 | Standing Ovation | Series B | $28.6M | 2026-03-31 | Paris | Biotech |
| 67 | Pinnacle Medicines | Series B | $89.0M | 2026-03-26 | Doylestown | Biotech |
| 68 | Yunying Medical | Series B | $14.2M | 2026-03-23 | Shanghai | Biotech |
| 69 | Crossbow Therapeutics | Series B | $77.0M | 2026-03-18 | Cambridge | Biotech |
| 70 | Unnatural Products | Series B | $45.0M | 2026-03-16 | Santa Cruz | Artificial intelligence |
| 71 | Puyi Biotech | Series B | $21.8M | 2026-03-16 | Beijing | Biotech |
| 72 | CSR Biotech | Series B | $45.0M | 2026-03-10 | Haidian | Biotech |
| 73 | Atavistik Bio | Series B | $40.0M | 2026-03-05 | Cambridge | Biotech |
| 74 | BreezeBio | Series B | $60.0M | 2026-02-25 | Brisbane | Artificial intelligence |
| 75 | Metagen Therapeutics | Series B | $7.7M | 2026-02-25 | Tsuruoka | Artificial intelligence |
| 76 | Parylene | Series B | $14.5M | 2026-02-23 | Jiading | Biotech |
| 77 | Altesa | Series B | $75.0M | 2026-02-19 | College Park | Biotech |
| 78 | Findcure | Series B | $14.5M | 2026-02-14 | Daxing | Biotech |
| 79 | Daxiang Biotech | Series B | $14.5M | 2026-02-13 | Haidian | Biotech |
| 80 | Transcend Vivoscope | Series B | $14.5M | 2026-02-10 | Haidian | Biotech |
| 81 | QuantX Biosciences | Series B | $85.0M | 2026-02-09 | Princeton | Biotech |
| 82 | Galux | Series B | $29.0M | 2026-02-09 | Dogokdong | Artificial intelligence |
| 83 | Kainova Therapeutics | Series B | $23.5M | 2026-02-09 | Montréal | Biotech |
| 84 | Pandorum Technologies | Series B | $18.0M | 2026-02-09 | Bengaluru | Biotech |
| 85 | Imbioray | Series B | $28.8M | 2026-02-05 | Hangzhou | Biotech |
| 86 | ecovia I bio | Series B | $1.5M | 2026-02-03 | Ann Arbor | Biotech |
| 87 | Epikast | Series B | $2.2M | 2026-01-30 | New York | Biotech |
| 88 | Neowise | Series B | $28.7M | 2026-01-26 | Suzhou | Biotech |
| 89 | Primmune Therapeutics | Series B | $23.3M | 2026-01-26 | San Diego | Biotech |
| 90 | PAQ Therapeutics | Series B | $38.0M | 2026-01-22 | Cambridge | Biotech |
| 91 | Orbem | Series B | $64.6M | 2026-01-20 | Munich | Artificial intelligence |
| 92 | Exciva | Series B | $59.4M | 2026-01-20 | Heidelberg | Biotech |
| 93 | Bo Shengji | Series B | 2026-01-19 | Suzhou | Biotech | |
| 94 | Alioth | Series B | $14.4M | 2026-01-15 | Shanghai | Biotech |
| 95 | Mirador Therapeutics | Series B | $250.0M | 2026-01-12 | San Diego | Biotech |
| 96 | Precede Biosciences | Series B | $63.5M | 2026-01-12 | Boston | Biotech |
| 97 | Juvena Therapeutics | Series B | $33.5M | 2026-01-12 | Redwood City | Biotech |
| 98 | Medefa | Series B | $1.4M | 2026-01-11 | Zhuhai | Biotech |
| 99 | Ruizhou Biotechnology | Series B | $28.6M | 2026-01-09 | Fengxian | Biotech |
| 100 | APOLLOMICS | Series B | $483K | 2026-01-09 | Nanjing | Biotech |
Table 1. The 100 most recent rounds. Source: FundingWatcher. Data as of 4 September 2026. Base: 1,411.
Largest rounds
Largest round first
100 rows
| # | Company | Round | Amount | Date | City | Sector |
|---|---|---|---|---|---|---|
| 1 | MGI Tech | Series B | $1.0B | 2020-05-28 | Shenzhen | Biotech |
| 2 | SFCC | Series B | $646.8M | 2022-12-09 | Shenzhen | Biotech |
| 3 | Kailera Therapeutics | Series B | $600.0M | 2025-10-14 | Waltham | Biotech |
| 4 | Laronde | Series B | $440.0M | 2021-08-30 | Cambridge | Biotech |
| 5 | Believer Meats | Series B | $347.0M | 2021-12-17 | Jerusalem | Biotech |
| 6 | Ollin Biosciences | Series B | $330.0M | 2026-06-24 | Austin | Biotech |
| 7 | Cardurion Pharmaceuticals | Series B | $260.0M | 2024-07-16 | Boston | Biotech |
| 8 | Kardigan | Series B | $254.0M | 2025-10-14 | South San Francisco | Biotech |
| 9 | Mirador Therapeutics | Series B | $250.0M | 2026-01-12 | San Diego | Biotech |
| 10 | AltruBio | Series B | $225.0M | 2024-05-21 | Los Altos | Biotech |
| 11 | Orna Therapeutics | Series B | $221.0M | 2022-08-16 | Cambridge | Biotech |
| 12 | Incode Technologies | Series B | $220.0M | 2021-12-07 | San Francisco | Biotech |
| 13 | Metsera | Series B | $215.0M | 2024-11-13 | New York | Biotech |
| 14 | Immunai | Series B | $215.0M | 2021-10-27 | New York | Artificial intelligence |
| 15 | Upstream Bio | Series B | $200.0M | 2023-06-08 | Waltham | Biotech |
| 16 | Sironax | Series B | $200.0M | 2022-08-02 | Beijing | Biotech |
| 17 | Aera Therapeutics | Series B | $193.0M | 2023-02-16 | Boston | Biotech |
| 18 | Osanni Bio | Series B | $190.0M | 2026-06-23 | San Francisco | Biotech |
| 19 | Marea Therapeutics | Series B | $190.0M | 2024-06-18 | San Francisco | Biotech |
| 20 | Repertoire Immune Medicines | Series B | $189.0M | 2021-04-13 | Cambridge | Biotech |
| 21 | Tune Therapeutics | Series B | $175.0M | 2025-01-12 | Durham | Biotech |
| 22 | Aktis Oncology | Series B | $175.0M | 2024-09-30 | Boston | Biotech |
| 23 | Capstan Therapeutics | Series B | $175.0M | 2024-03-20 | San Diego | Biotech |
| 24 | Mariana Oncology | Series B | $175.0M | 2023-09-07 | Watertown | Biotech |
| 25 | Asimov | Series B | $175.0M | 2023-01-05 | Boston | Artificial intelligence |
| 26 | Haihe Biopharma | Series B | $171.0M | 2020-07-24 | Shanghai | Biotech |
| 27 | Instil Bio | Series B | $170.2M | 2020-08-03 | Dallas | Biotech |
| 28 | AffaMed Therapeutics | Series B | $170.0M | 2021-03-30 | New City | Biotech |
| 29 | Barinthus Biotherapeutics | Series B | $168.0M | 2021-03-17 | Harwell | Biotech |
| 30 | Windward Bio | Series B | $165.0M | 2026-05-04 | Basel | Biotech |
| 31 | Nuvig Therapeutics | Series B | $161.0M | 2024-12-05 | Redwood City | Biotech |
| 32 | Frontera Therapeutics | Series B | $160.0M | 2022-06-24 | Bedford | Biotech |
| 33 | Genor Biopharma | Series B | $160.0M | 2020-06-01 | Beijing | Biotech |
| 34 | Engrail Therapeutics | Series B | $157.0M | 2024-03-19 | San Diego | Biotech |
| 35 | Quell Therapeutics | Series B | $156.0M | 2021-11-29 | London | Biotech |
| 36 | AIRNA | Series B | $155.0M | 2025-04-01 | Cambridge | Biotech |
| 37 | Strand Therapeutics | Series B | $153.0M | 2025-08-03 | Cambridge | Biotech |
| 38 | Vaderis Therapeutics | Series B | $152.0M | 2026-08-11 | Basel | Biotech |
| 39 | Graphite Bio | Series B | $150.7M | 2021-03-15 | South San Francisco | Biotech |
| 40 | Syneron | Series B | $150.0M | 2026-03-31 | Guangzhou | Artificial intelligence |
| 41 | Latigo Biotherapeutics | Series B | $150.0M | 2025-03-17 | Thousand Oaks | Biotech |
| 42 | Septerna | Series B | $150.0M | 2023-07-11 | San Francisco | Biotech |
| 43 | Alkeus Pharmaceuticals | Series B | $150.0M | 2023-06-05 | Cambridge | Biotech |
| 44 | MOMA Therapeutics | Series B | $150.0M | 2022-05-10 | Cambridge | Biotech |
| 45 | BostonGene | Series B | $150.0M | 2022-04-06 | Waltham | Biotech |
| 46 | JOINN Biologics | Series B | $150.0M | 2021-08-01 | Richmond | Biotech |
| 47 | WuXi Diagnostics | Series B | $150.0M | 2021-02-23 | Shanghai | Biotech |
| 48 | Visen Pharmaceuticals | Series B | $150.0M | 2021-01-08 | Shanghai | Biotech |
| 49 | Noema Pharma | Series B | $147.2M | 2024-12-11 | Basel | Biotech |
| 50 | Azafaros | Series B | $146.7M | 2025-05-13 | Leiden | Biotech |
| 51 | Zhaoke Ophthalmology Pharmaceutical | Series B | $145.0M | 2020-10-12 | Hong Kong | Biotech |
| 52 | Outpace Bio | Series B | $144.0M | 2024-08-01 | Seattle | Biotech |
| 53 | Abdera Therapeutics | Series B | $142.0M | 2023-04-20 | Vancouver | Biotech |
| 54 | AAVantgarde Bio | Series B | $141.0M | 2025-11-03 | Milano | Biotech |
| 55 | Avistone Pharmaceuticals | Series B | $140.7M | 2023-12-28 | Beijing | Biotech |
| 56 | Harbinger Health | Series B | $140.0M | 2023-09-28 | Cambridge | Artificial intelligence |
| 57 | RVAC Medicines | Series B | $140.0M | 2022-04-26 | Singapore | Biotech |
| 58 | Shoreline Biosciences | Series B | $140.0M | 2021-11-02 | La Jolla | Biotech |
| 59 | Sidewinder Therapeutics | Series B | $137.0M | 2026-04-08 | San Diego | Biotech |
| 60 | VelosBio | Series B | $137.0M | 2020-07-08 | San Diego | Biotech |
| 61 | Splice Bio | Series B | $135.0M | 2025-06-11 | Barcelona | Biotech |
| 62 | Chroma Medicine | Series B | $135.0M | 2023-02-28 | Cambridge | Biotech |
| 63 | Juno Therapeutics | Series B | $134.0M | 2014-08-05 | Seattle | Biotech |
| 64 | ARTBIO | Series B | $132.0M | 2025-07-29 | Cambridge | Biotech |
| 65 | Alterome Therapeutics | Series B | $132.0M | 2024-04-03 | San Diego | Biotech |
| 66 | Crystalys Therapeutics | Series B | $130.0M | 2026-07-22 | San Diego | Biotech |
| 67 | Protego Biopharma | Series B | $130.0M | 2025-12-01 | San Diego | Biotech |
| 68 | GlycoEra | Series B | $130.0M | 2025-05-27 | Wädenswil | Biotech |
| 69 | Halda Therapeutics | Series B | $126.0M | 2024-08-12 | New Haven | Biotech |
| 70 | SonoThera | Series B | $125.0M | 2026-06-10 | South San Francisco | Biotech |
| 71 | Ray Therapeutics | Series B | $125.0M | 2026-04-21 | San Diego | Biotech |
| 72 | Diagonal Therapeutics | Series B | $125.0M | 2026-01-08 | Watertown | Biotech |
| 73 | Santa Ana Bio | Series B | $125.0M | 2024-06-13 | Alameda | Biotech |
| 74 | Design Therapeutics | Series B | $125.0M | 2021-01-27 | Solana Beach | Biotech |
| 75 | CREATE Medicines | Series B | $122.0M | 2026-05-14 | Cambridge | Biotech |
| 76 | Triana Biomedicines | Series B | $120.0M | 2025-12-03 | Lexington | Biotech |
| 77 | FIRE1 | Series B | $120.0M | 2025-01-07 | Dublin | Biotech |
| 78 | Idrx | Series B | $120.0M | 2024-08-07 | Cambridge | Biotech |
| 79 | Pheon Therapeutics | Series B | $120.0M | 2024-05-21 | London | Biotech |
| 80 | OriginCell | Series B | $120.0M | 2022-08-01 | Pudong | Biotech |
| 81 | Remilk | Series B | $120.0M | 2022-01-04 | Tel Aviv | Biotech |
| 82 | Claris Biotherapeutics | Series B | $118.0M | 2026-07-28 | Jersey City | Biotech |
| 83 | Helio Health | Series B | $118.0M | 2021-07-15 | Irvine | Artificial intelligence |
| 84 | Amunix | Series B | $117.0M | 2021-03-04 | South San Francisco | Biotech |
| 85 | Expedition Therapeutics | Series B | $115.0M | 2026-08-05 | San Francisco | Biotech |
| 86 | SalioGen Therapeutics | Series B | $115.0M | 2022-01-05 | Burlington | Biotech |
| 87 | Talaris Therapeutics | Series B | $115.0M | 2020-10-06 | Louisville | Biotech |
| 88 | Semma Therapeutics | Series B | $114.0M | 2017-11-29 | Cambridge | Biotech |
| 89 | ProfoundBio | Series B | $112.0M | 2024-02-13 | Seattle | Biotech |
| 90 | Sanegene Bio | Series B | $110.0M | 2025-12-08 | Woburn | Biotech |
| 91 | Curevo | Series B | $110.0M | 2025-03-17 | Bothell | Biotech |
| 92 | T-knife | Series B | $110.0M | 2021-08-02 | Berlin | Biotech |
| 93 | Alltrna | Series B | $109.0M | 2023-08-09 | Cambridge | Biotech |
| 94 | D3 Bio | Series B | $108.0M | 2025-12-09 | Wuxi Shi | Biotech |
| 95 | EpiBiologics | Series B | $107.0M | 2026-01-08 | San Mateo | Biotech |
| 96 | Profluent Bio | Series B | $106.0M | 2025-11-19 | Emeryville | Artificial intelligence |
| 97 | Pathalys Pharma | Series B | $105.0M | 2024-08-20 | Raleigh | Biotech |
| 98 | Variant Bio | Series B | $105.0M | 2021-11-09 | Seattle | Biotech |
| 99 | Akouos | Series B | $105.0M | 2020-03-03 | Boston | Biotech |
| 100 | Purespring Therapeutics | Series B | $104.5M | 2024-10-09 | London | Biotech |
Table 2. The 100 largest rounds. Source: FundingWatcher. Data as of 4 September 2026. Base: 1,411.
By month
| Month | Companies |
|---|---|
| 2024-09 | 18 |
| 2024-10 | 11 |
| 2024-11 | 9 |
| 2024-12 | 10 |
| 2025-01 | 11 |
| 2025-02 | 9 |
| 2025-03 | 10 |
| 2025-04 | 14 |
| 2025-05 | 11 |
| 2025-06 | 6 |
| 2025-07 | 11 |
| 2025-08 | 12 |
| 2025-09 | 22 |
| 2025-10 | 20 |
| 2025-11 | 12 |
| 2025-12 | 20 |
| 2026-01 | 25 |
| 2026-02 | 13 |
| 2026-03 | 10 |
| 2026-04 | 12 |
| 2026-05 | 11 |
| 2026-06 | 18 |
| 2026-07 | 10 |
| 2026-08 | 12 |
Table 3. Biotech startups that raised Series B by month of the round. Source: FundingWatcher. Data as of 4 September 2026. Base: 1,411.
Country
| Country | Companies |
|---|---|
| United States | 677 |
| China | 293 |
| South Korea | 75 |
| United Kingdom | 72 |
| France | 37 |
| Germany | 35 |
| Switzerland | 30 |
| Israel | 26 |
| Japan | 23 |
| Canada | 18 |
| The Netherlands | 15 |
| Belgium | 15 |
| Spain | 10 |
| Australia | 10 |
| Singapore | 10 |
Table 4. Biotech startups that raised Series B by country. Source: FundingWatcher. Data as of 4 September 2026. Base: 1,411.
City
| City | Companies |
|---|---|
| Cambridge | 66 |
| San Diego | 52 |
| Shanghai | 50 |
| Boston | 37 |
| San Francisco | 33 |
| Beijing | 31 |
| Suzhou | 27 |
| New York | 26 |
| Seoul | 24 |
| Seattle | 23 |
| London | 23 |
| Hangzhou | 22 |
| Shenzhen | 19 |
| South San Francisco | 14 |
| Waltham | 14 |
Table 5. Biotech startups that raised Series B by city. Source: FundingWatcher. Data as of 4 September 2026. Base: 1,411.
Sector
| Sector | Companies |
|---|---|
| Biotech | 1,411 |
| Health care | 1,221 |
| Software | 136 |
| Artificial intelligence | 73 |
| Hardware | 45 |
| Cybersecurity | 11 |
| Fintech | 10 |
| Energy | 8 |
| Commerce | 5 |
| Education | 5 |
Table 6. Biotech startups that raised Series B by sector. Source: FundingWatcher. Data as of 4 September 2026. Base: 1,411.
Biotech at other stages
Other sectors that raised Series B
software startups that raised Series B5,716
health care startups that raised Series B2,747
AI startups that raised Series B1,576
fintech startups that raised Series B1,502
commerce startups that raised Series B1,534
hardware startups that raised Series B2,352
education startups that raised Series B485
cybersecurity startups that raised Series B643
energy startups that raised Series B508
Cite: FundingWatcher, 1,411 biotech companies whose most recent round is Series B, 4 September 2026. https://fundingwatcher.com/startups/biotech/series-b/